Calamos Wealth Management »

Bridgebio Pharma shares owned by Calamos Wealth Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Calamos Wealth Management from 13F filings

Historical chart of Calamos Wealth Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Calamos Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Calamos Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $84k 60k 1.40
2025-06-30 $75k 60k 1.25
2025-03-31 $86k 75k 1.14

More positions owned by Calamos Wealth Management

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr S&p 500 Val Etf (IVE)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Ishares Tr Russell 3000 Etf (IWV)
Broadcom (AVGO)
Ishares Tr Msci Acwi Ex Us (ACWX)
Meta Platforms Cl A (META)
Victory Portfolios Ii Core Intermediat (UITB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Scp Etf (IJR)

View all positions for Calamos Wealth Management

Top funds holding Bridgebio Pharma

Wolverine Asset Management
Linden Advisors
Weiss Asset Management LP[1
Tenor Capital Management
Citadel Advisors
Graham Capital Management
Balyasny Asset Management
Ing Investment Management
Capstone Investment Advisors
Lazard Asset Management
683 Capital Management
Lord, Abbett & Co
M&G
Morgan Stanley
State Street Corporation

View all funds holding Bridgebio Pharma